UK markets open in 7 hours 4 minutes

Atossa Therapeutics, Inc. (ATOS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.6849+0.0248 (+3.76%)
At close: 04:00PM EDT
0.6601 -0.02 (-3.62%)
After hours: 07:50PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 91.17M
Enterprise value -48.87M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.67
Enterprise value/revenue N/A
Enterprise value/EBITDA 2.01

Trading information

Stock price history

Beta (5Y monthly) 1.25
52-week change 3-51.82%
S&P500 52-week change 3-14.12%
52-week high 31.4200
52-week low 30.5000
50-day moving average 30.7570
200-day moving average 30.8507

Share statistics

Avg vol (3-month) 3495.54k
Avg vol (10-day) 3280.61k
Shares outstanding 5126.62M
Implied shares outstanding 6N/A
Float 8118.83M
% held by insiders 10.04%
% held by institutions 120.65%
Shares short (14 Mar 2023) 48.6M
Short ratio (14 Mar 2023) 426.55
Short % of float (14 Mar 2023) 46.80%
Short % of shares outstanding (14 Mar 2023) 46.80%
Shares short (prior month 14 Feb 2023) 48.74M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 319 Apr 2018
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 319 Apr 2018

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-13.07%
Return on equity (ttm)-21.05%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -27.68M
Net income avi to common (ttm)-26.96M
Diluted EPS (ttm)-0.1900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)110.89M
Total cash per share (mrq)0.88
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)21.23
Book value per share (mrq)0.93

Cash flow statement

Operating cash flow (ttm)-20.76M
Levered free cash flow (ttm)-10.54M